Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II-III
文献类型：期刊论文
| 作者 | Li, Jingjing1,2,3; Xu, Qi1,2,3; Luo, Cong1,2,3; Chen, Lei1,2,3; Ying, Jieer1,2,3 |
| 刊名 | TRANSLATIONAL CANCER RESEARCH
 |
| 出版日期 | 2020-09-01 |
| 卷号 | 9 |
| 关键词 | Gastric cancer CEA CA125 CA19-9 AFP |
| ISSN号 | 2218-676X |
| DOI | 10.21037/tcr-19-2427 |
| 通讯作者 | Ying, Jieer(jieerying@aliyun.com) |
| 英文摘要 | Background: Gastric cancer is one of the high occurrence cancers among gastrointestinal tumor. Further research should be carried out to find more prognostic factors, screening patients with poor prognosis, who need stronger treatment. Methods: The clinicopathologic characteristic, the levels of tumor markers and survival of 105 patients who underwent gastrectomy with a D2 lymph node dissection in Zhejiang Cancer Hospital were collected and analyzed. Results: In the 105 patients, there were 71 males, and the median age was 56 years (range, 21-83 years). In 105 patients, 77 patients were diagnosed with non-cardia cancer, 84.8% patients were diagnosed of poorly differentiated adenocarcinoma, more than half of the patients were diagnosed of T3-4, and 92 patients had lymph node metastasis, while the clinical stage III patients were accounted for 85%. Seventy point five percent patients were Borrmann III type. The median OS of the patients with increased preoperative serum CEA, CA125, CA19- 9, AFP and combined were shorter than those patients with normal serum tumor markers, but without statistical significance (P=0.350, P=0.498, P=0.240, P=0.578 and P=0.219). The OS of patients with elevated levels of CEA, CA19-9, and AFP after operation were shorter than patients with decreased ones without statistical significance (P=0.321, P= 0.118 and P=0.424). Elevated CA125 after operation was shorter than patients with decreased ones significantly (P<0.005). Conclusions: Elevated of CA125 after operation was associated with poor OS in stage II-III GC patients. |
| WOS关键词 | RANDOMIZED CLINICAL-TRIAL ; CARCINOEMBRYONIC ANTIGEN ; CURATIVE RESECTION ; ALPHA-FETOPROTEIN ; D2 GASTRECTOMY ; TUMOR-MARKERS ; D1 |
| 资助项目 | Zhejiang Science and Technology Office Project Foundation[2016KYA050] |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000575123400010 |
| 出版者 | AME PUBL CO |
| 资助机构 | Zhejiang Science and Technology Office Project Foundation |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/104320]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 通讯作者 | Ying, Jieer |
| 作者单位 | 1.Chinese Acad Sci, Inst Canc & Basic Med ICBM, Hangzhou, Peoples R China 2.Univ Chinese Acad Sci, Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China 3.Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China |
| 推荐引用方式 GB/T 7714 | Li, Jingjing,Xu, Qi,Luo, Cong,et al. Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II-III[J]. TRANSLATIONAL CANCER RESEARCH,2020,9. |
| APA | Li, Jingjing,Xu, Qi,Luo, Cong,Chen, Lei,&Ying, Jieer.(2020).Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II-III.TRANSLATIONAL CANCER RESEARCH,9. |
| MLA | Li, Jingjing,et al."Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II-III".TRANSLATIONAL CANCER RESEARCH 9(2020). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。